Download Free National Synthetic Drugs Action Plan Book in PDF and EPUB Free Download. You can read online National Synthetic Drugs Action Plan and write the review.

It is urgent that parents of teenagers become fully informed on the risks associated with synthetic drugs, also known as “designer drugs.” The United States – especially parents and their teenage children -- face an array of drugs of abuse. Many, such as cocaine, heroin, and marijuana have confronted us for decades. The federal government has developed programs and initiatives to combat these drugs—to prevent use, treat the addicted, and disrupt production and the marketplace for drugs. But the significant threat to the nation posed by synthetic drugs, especially methamphetamine and MDMA, or “Ecstasy,” is a more recent phenomenon. A related threat is the growth in nonmedical use of pharmaceutical controlled substances. Diversion of these legitimate drugs is fueled in part by easy access over the Internet. The most recent NSDUH and other data indicate that we continue to confront increased use of such drugs, notably pain relievers and tranquilizers. This document recommends some new approaches to address this challenge.The United States and its parents face an array of drugs of abuse by teenagers and students. Many, such as cocaine, heroin, and marijuana have confronted us for decades. We have developed programs and initiatives to combat these drugs—to prevent use, treat the addicted, and disrupt production and the marketplace for drugs. The significant threat to the nation posed by synthetic drugs, especially methamphetamine and MDMA, or “Ecstasy,” is a more recent phenomenon. Initial efforts to confront synthetic drugs are already showing results. As demonstrated by the findings of the most recent National Survey on Drug Use and Health (formerly known as the National Household Survey on Drug Abuse) and the 2003 Monitoring the Future study, when we collectively push back, the synthetic drugs threat also will decline.A related threat is the growth in nonmedical use of pharmaceutical controlled substances. Diversion of these legitimate drugs is fueled in part by easy access over the Internet. The most recent NSDUH and other data indicate that we continue to confront increased use of such drugs, notably pain relievers and tranquilizers. This document recommends some new approaches to address this challenge.This document is a product of the hard work of the Department of Justice Criminal Division's Narcotic and Dangerous Drug Section, in cooperation with the Drug Enforcement Administration and several other agencies, and in consultation with various components of the Department of Health and Human Services. We are grateful for their efforts. The Action Plan represents an important step forward in our nation's effort to control dangerous synthetic drugs and pharmaceutical products and, moreover, in the continued achievement of the objectives set forth in the President's National Drug Control Strategy.
The President's National Drug Control Strategy describes the Administration's strategic approach for reducing illicit drug use in the United States. The Administration's Synthetic Drug Control Strategy is a companion to the National Strategy. It follows the main principles set out in the National Strategy: that supply and demand are the ultimate drivers in all illicit drug markets and that a balanced approach incorporating prevention, treatment, and market disruption initiatives (such as interdiction, arrests, prosecutions, and regulatory interventions) is the best way to reduce the supply of, and demand for, illicit drugs. The Synthetics Strategy also adheres to the format of the National Strategy by setting ambitious goals for reducing synthetic drug use at a rate approximating 5 percent each year. Specifically, the Synthetics Strategy outlines a strategy for reducing past month methamphetamine use by 15 percent over three years and past month prescription drug abuse2 by 15 percent over three years. Additionally, because the production of methamphetamine poses significant human and environmental risks, the Administration has also set a goal of reducing domestic methamphetamine Labouratories by 25 percent over three years. This and past administrations have traditionally avoided promulgating drug control strategies focused on a single drug or a single category of drugs. However, the unique nature of illicit markets for synthetic drugs warrants a targeted response, partly because those markets contain unique challenges and vulnerabilities. Unlike marijuana or cocaine, for example, either the final synthetic drug (as with prescription drugs) or its ingredients (as with methamphetamine) are designed for legal possession and use. Other reasons include the extreme health and environmental problems associated with the production of drugs such as methampheamine and the indisputably destructive nature of methamphetamine use itself. The Synthetics Strategy adheres to the following outline. Following this introduction, it describes the state of the illicit markets for methamphetamine and controlled substance prescription drugs, including progress made over the last several years. It then sets targets for reduced numbers in three principal categories: illicit methamphetamine use, domestic methamphetamine Labouratories, and the illicit use of controlled substance prescription drugs. This portion explains the fundamental principles and insights guiding the Synthetics Strategy and describes how performance goals will be measured. Next, the document describes the strategy itself, explaining how, given the current state of the illicit synthetic drug market, the Administration will meet targets for use and production by the end of 2008. Here, both supply reduction and demand reduction activities are addressed for both methamphetamine use and controlled substance prescription drug abuse. Finally, the end of the document addresses the problem of responding to the aftermath of methamphetamine production. Improving our knowledge about the health and environmental consequences of methamphetamine labs is critically important toward improving the safety and security of Americans, including the children who are found in or near toxic Labouratories.
This is a print on demand edition of a hard to find publication. Presents the Admin¿s. strategy for responding to the illicit use and production of methamphetamine (meth), and the illicit use, or non-medical use, of controlled substance prescription drugs (CSPDA). This 2006 Strategy aims for a 15% reduction in meth use over 3 years; a 15% reduction in the abuse of CSPDA over 3 years; and a 25% reduction in domestic meth. labs. over 3 years. Contents: (1) Progress; (2) Meth Supply: A Concurrent Internat. and Domestic Focus; The Fed. Gov¿ts. Internat. Meth Strategy; Treating Meth Users; Prevention; (3) CSPDA; Doctor Shopping and Prescription Fraud; Illegal Online Pharmacies; (4) Following the Aftermath of Meth Production; The First 24 Hours: Securing Lab. Sites; Remediation; Helping Child Victims of Meth.